Literature DB >> 12740913

EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells.

Elena Kashuba1, Karin Mattsson, Katja Pokrovskaja, Csaba Kiss, Marina Protopopova, Barbro Ehlin-Henriksson, George Klein, Laszlo Szekely.   

Abstract

Epstein-Barr virus (EBV) carrying lymphoblastoid cells of normal origin express the full program of all 9 virus-encoded, growth transformation associated proteins. They have an intact p53 pathway as a rule. This raises the question of whether any of the viral proteins impair the pathway functionally. Using a yeast 2-hybrid system, we have shown that EBNA-5 but not the other EBNAs interacts with the p14ARF protein, a regulator of the p53 pathway. The interaction was confirmed in vitro using a GST pull-down assay. Moreover, expression of EBNA-5 increased the survival of p14ARF-transfected cells. EBV infection of resting B cells induced the expression of p14ARF mRNA without increased level of the protein. A fraction of the p14ARF localized to the nucleoli but the bulk of the protein accumulated in nuclear but extranucleolar inclusions. Formation of the extranucleolar inclusions led to complete relocalization of EBNA-5 from nucleoplasm to these structures. The inclusions also contained p53 and HDM2, and were surrounded by PML bodies and proteasomes, which suggests that these inclusions could be targets for proteasome dependent protein degradation. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740913     DOI: 10.1002/ijc.11124

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.

Authors:  Rongsheng Peng; Stephanie C Moses; Jie Tan; Elisabeth Kremmer; Paul D Ling
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  Study on the spatial architecture of p53, MDM2, and p14ARF containing complexes.

Authors:  Andrej Savchenko; Mariya Yurchenko; Boris Snopok; Elena Kashuba
Journal:  Mol Biotechnol       Date:  2008-11-07       Impact factor: 2.695

3.  Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100.

Authors:  Paul D Ling; Rong Sheng Peng; Ayako Nakajima; Jiang H Yu; Jie Tan; Stephanie M Moses; Wei-Hong Yang; Bo Zhao; Elliott Kieff; Kenneth D Bloch; Donald B Bloch
Journal:  EMBO J       Date:  2005-09-22       Impact factor: 11.598

4.  PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.

Authors:  Lisa Ivanschitz; Yuki Takahashi; Florence Jollivet; Olivier Ayrault; Morgane Le Bras; Hugues de Thé
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

5.  Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.

Authors:  Lenka Skalska; Robert E White; Gillian A Parker; Ernest Turro; Alison J Sinclair; Kostas Paschos; Martin J Allday
Journal:  PLoS Pathog       Date:  2013-02-21       Impact factor: 6.823

6.  Dual Role of p53 in Innate Antiviral Immunity.

Authors:  Carmen Rivas; Stuart A Aaronson; Cesar Munoz-Fontela
Journal:  Viruses       Date:  2010-01-22       Impact factor: 5.818

Review 7.  EBV and Apoptosis: The Viral Master Regulator of Cell Fate?

Authors:  Leah Fitzsimmons; Gemma L Kelly
Journal:  Viruses       Date:  2017-11-13       Impact factor: 5.048

Review 8.  Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis.

Authors:  Ahmed El-Sharkawy; Lobna Al Zaidan; Ahmed Malki
Journal:  Front Oncol       Date:  2018-08-02       Impact factor: 6.244

9.  Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.

Authors:  Grzegorz Sarek; Sari Kurki; Juulia Enbäck; Guergana Iotzova; Juergen Haas; Pirjo Laakkonen; Marikki Laiho; Päivi M Ojala
Journal:  J Clin Invest       Date:  2007-03-15       Impact factor: 14.808

10.  PRIMA-1MET induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein.

Authors:  György Stuber; Emilie Flaberg; Gabor Petranyi; Rita Otvös; Nina Rökaeus; Elena Kashuba; Klas G Wiman; George Klein; Laszlo Szekely
Journal:  Mol Cancer       Date:  2009-03-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.